Successful Treatment With Sorafenib for Sunitinib-Refractory Metastatic Papillary Renal Cell Carcinoma: Potential Impact of Raf Overexpression on Predicting the Efficacy of Sorafenib

IJU Case Reports
doi 10.1002/iju5.12035
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy